2 active not recruiting, 2 recruiting, 1 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Active not recruiting 2, Recruiting 2, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Malignant Genitourinary System Neoplasm: new trials by email Literature Review of Malignant Genitourinary System Neoplasm trials Research Report on Malignant Genitourinary System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 800 | 2021-02-21 | 2026-07-15 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Fecal Microbiota Transplantation, Loperamide - Colitis, Diarrhea | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 40 | 2021-02-01 | 2026-09-18 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm | Phase 1 | Completed | Mayo Clinic | 230 | 2020-06-29 | 2023-07-24 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 152 | 2015-07-22 | 2026-11-12 |
Urogenital Neoplasms (5) · Colitis (3) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Melanoma (2) · Brain Neoplasms (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Diarrhea (1) · Digestive System Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms, Unknown Primary (1) · Ovarian Neoplasms (1) · Penile Neoplasms (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Urogenital Diseases (5) · Digestive System Diseases (4) · Colonic Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Lung Diseases (3) · Neoplasms by Histologic Type (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3)
CT-P13 (2) · Disulfides (2) · Fecal Microbiota Transplantation (2) · Immunoglobulin G (2) · Infliximab (2) · LDP-02 (2) · vedolizumab (2) · Biopsy (1) · CTLA-4 Antigen (1) · Endoscopy (1) · Genetic Counseling (1) · Genetic Testing (1) · Ipilimumab (1) · Loperamide (1) · Magnetic Resonance Spectroscopy (1)
M.D. Anderson Cancer Center (3) · Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (5)
Yinghong Wang (3) · Andrea B Apolo (1) · Niloy J Samadder (1)
PMID 32915679, PMID 35031545, PMID 38954785, PMID 42735684
UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1), ZIABC011078 (1)